Alteration of Biochemical Profiles after High-Dose Intravenous Immunoglobulin Administration in Kawasaki Disease

@article{Lee2002AlterationOB,
  title={Alteration of Biochemical Profiles after High-Dose Intravenous Immunoglobulin Administration in Kawasaki Disease},
  author={K. Y. Lee and Ji Whan Han and Jae Seung Lee and Kevin T Whang},
  journal={Acta paediatrica},
  year={2002},
  volume={91 2},
  pages={164-7}
}
UNLABELLED Intravenous immunoglobulin (IVIG) has been used as an immunomodulatory treatment for several immune-mediated diseases. Early effects of high-dose IVIG treatment on biochemical profiles including lipids and proteins were evaluated in patients with Kawasaki disease (KD). Twelve children with KD (9 boys) were treated with IVIG at 2 g/kg over a period of 12 h. Serial sera samples were collected from the patients four times: before IVIG treatment and 2 h, 24 h and 7 d after IVIG treatment… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Mechanism of intravenous immune globulin therapy.

The New England journal of medicine • 1999

Serum HDL level at acute stage of Kawasaki disease.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui • 1998

Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease

AN Ching, B Hwang, +3 authors CC Meng
Clin Chim Acta • 1997

The use of intravenous immune globulin in immunodeficiency disease

RH Bukley, RI Schiff
N Engl J Med • 1992

Similar Papers

Loading similar papers…